A Loss of Insulin-like Growth Factor-2 Imprinting Is Modulated by CCCTC-binding Factor Down-regulation at Senescence in Human Epithelial Cells
The imprinted insulin-like growth factor-2 (IGF2) gene is an auto/paracrine growth factor expressed only from the paternal allele in adult tissues. In tissues susceptible to aging-related cancers, including the prostate, a relaxation ofIGF2imprinting is found, suggesting a permissive role for epigenetic alterations in cancer development. To determine whetherIGF2imprinting is altered in cellular aging and senescence, human prostate epithelial and urothelial cells were passaged serially in culture to senescence. Allelic analyses using anIGF2polymorphism demonstrated a complete conversion of theIGF2imprint status from monoallelic to biallelic, in which the development of senescence was associated with a 10-fold increase inIGF2expression. As a mechanism, a 2-fold decrease in the binding of the enhancer-blocking element CCCTC-binding factor (CTCF) within the intergenicIGF2-H19region was found to underlie this switch to biallelicIGF2expression in senescent cells. This decrease in CTCF binding was associated with reduced CTCF expression in senescent cells. Node novoincreases in methylation at theIGF2CTCF binding site were seen. The forced down-regulation of CTCF expression using small interfering RNA in imprinted prostate cell lines resulted in an increase inIGF2expression and a relaxation of imprinting. Our data suggest a novel mechanism forIGF2imprinting regulation, that is, the reduction of CTCF expression in the control ofIGF2imprinting. We also demonstrate that altered imprinting patterns contribute to changes in gene expression in aging cells.